BSE: SUNPHARMA - Sun Pharmaceutical Industries Limited

Rentabilidade por seis meses: +21.32%
Setor: Healthcare

Relatórios Sun Pharmaceutical Industries Limited

Capitalização

IFRS
Relatórios Anual Trimestral
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Média de 5 anos CAGR 5
Капитализация, млрд ₹
1 388.95 2 420 2 400 2 720
Выручка, млрд ₹
284.87 315.78 264.89 290.66 328.38 334.98 386.54 438.86 477.58 477.58
Чистая прибыль, млрд ₹
45.46 69.64 20.96 26.65 37.65 29.04 32.73 84.74 95.76 95.76
EV, млрд ₹
1 418.14 1 183.06 924.85 2 310 2 380.13 2 380.13
EBIT, млрд ₹
69.66 75.39 85.72 40.9 47.37 49.48 64.28 81.47 92.43 92.43
EBITDA, млрд ₹
54.3 60.89 73.53 50.2 67.52 121.1 121.1
Баланс стоимость, млрд ₹
329.82 366.4 383.14 414.09 452.64 464.63 480.11 559.95 636.67 636.67
FCF, млрд ₹
19.46 -10.16 50.13 50 74.9 28.74 99.33 99.33
Операционный денежный поток, млрд ₹
66.86 70.82 39.07 21.96 65.55 61.7 89.85 55.26 121.35 121.35
Операционная прибыль, млрд ₹
68.74 86.26 33.83 36.88 47.69 21.47 35.78 90.92 104.68 104.68
Операционные расходы, млрд ₹
205.7 227.36 224.02 243.41 279.02 270.8 299.49 340.35 372.9 372.9
CAPEX, млрд ₹
34.04 36.93 19.61 32.13 15.42 11.7 14.95 20.86 22.02 22.02


Balanço Patrimonial

IFRS
Relatórios Anual Trimestral
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Média de 5 anos CAGR 5
Наличность, млрд ₹
53.89 51.05 55.15 34.31 19.1 30 26.77 43.7 92.86 92.86
Short Term Investments ₹
7.47 3.27 60.52 41.17 52.63 31.3 76.96 93.9 100.43 100.43
Long term investments ₹
7.88 5.99 19.14 14.91
Total Receivables ₹
67.61 84.98 84.16 100.63 94.21 90.61 105.93 114.39 112.49 112.49
Total Current Assets ₹
299.41 329.54 316.36 310.69 316.54 304.42 350.15 398.62 434.75 434.75
Чистые активы, млрд ₹
85.07 87.87 100.6 105.94 109.38 112.26 111.72 111.69 113.54 113.54
Активы, млрд ₹
555.3 614.1 645.16 646.94 682.52 676.67 698.08 807.44 854.63 854.63
Short Term Debt ₹
52.06 66.55 79.8 83.71 55.49 24.45 4.69 59.58 28.44 28.44
Long Term Debt ₹
30.39 13.7 16.69 14.23 17.78 6.55 4.82 5.6 0.0133 0.0133
Задолженность, млрд ₹
225.48 247.71 262.02 232.85 229.88 212.04 217.97 247.48 183.57 183.57
Чистый долг, млрд ₹
23.34 33.17 22.94 3.43 -17.27 21.34 -64.4 -64.4
Долг, млрд ₹
82.45 80.25 96.48 97.94 73.27 31 9.5 65.18 28.46 28.46
Interest income ₹
3.54 4.32 0.5693 0.478 1.24 5.86 5.35 2.81
Расходы на обслуживание долга ₹
5.25 2.91 1.41 1.27 1.72 2.38 2.38
Чист. проц. доходы, млрд ₹
0.4084 0.6825 1.44 0.6407 0.7004 4.26 -1.72 10.23 2.81
Goodwill ₹
29.12 50.61 56.35 55.36 56.07 59.56 64.81 62.88 65.91 87.13
Себестоимость, млрд ₹
77.13 96.95 89 92.39 104.71 98.85 117.08 119.42 120.7 120.7
Товарно материальные запасы ₹
64.23 77.35 68.81 78.86 82.69 93.62 93.11 105.13 98.68 98.68


Promoção

IFRS
Relatórios Anual Trimestral
2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Média de 5 anos CAGR 5
EPS 19.61 28.92 9.01 11.01 15.69 12.1 13.64 35.32 39.91 39.91
Цена акции ао 629.75 570.8 430.65 432.5 592.35 845.4 1000.7 1260 1841.5 1841.5
Число акций ао, млн 2399.3 2399.33 2399.33 2399 2399.33 2399.33 2399.33 2399.33
FCF/акцию -4.24 20.89 20.84 31.21 11.98 41.4 41.4


Eficiência

IFRS
Relatórios Anual Trimestral
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Média da indústria Média de 5 anos CAGR 5
ROE, % 13.78 19.01 5.47 6.44 8.32 6.25 6.93 16.29 16.01 16.01 -10.48
ROA, % 8.19 11.34 3.25 4.12 5.52 4.29 4.76 11.26 11.52 11.52 -0.93
ROIC, % 13.47 12.78 16.13 6.03 6.14 9.78 9.01 11.83 18.19 18.19 18.20
ROS, % 22.05 7.91 9.17 11.47 8.67 8.47 19.31 20.05 20.05 20.05 -86.65
ROCE, % 24.45 22.86 23.4 10.67 11.44 10.93 13.83 15.49 15.19 16.51 5.70
Рентаб EBITDA, % 20.5 20.95 22.39 14.99 17.47 27.59 27.59 6.37
Чистая рентаб, % 15.96 22.05 7.91 9.17 11.47 8.67 8.47 19.31 20.05 20.05 -86.65
Operation Margin, % 27.32 12.77 12.69 14.52 6.41 9.26 20.72 21.92 21.92 21.92 -90.90


Chances

IFRS
Relatórios Anual Trimestral
2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Média da indústria Média de 5 anos CAGR 5
P/E
19.94 43.14 23.96 50.47 66.59 27.84 40.29 40.29 43.40
P/BV
3.79 2.78 1.99 3.15 4.54 4.21 5.75 5.75 24.61
P/S
4.4 3.96 2.75 4.38 5.64 5.37 8.08 8.08 39.08
P/FCF
94.64 27.38 27.38 27.38 -113.38
E/P
0.0501 0.0312 0.0352 0.0352 0.0352 0.01
EV/EBITDA
19.43 12.58 30.34 19.65 19.65 9.94
EV/Ebit
18.69 25.75 25.75 25.75 25.75
EV/S
4.49 2.82 5.42 4.98 4.98 4.98 38.65
EV/FCF
18.45 82.82 23.96 23.96 23.96 -193.31
Debt/EBITDA
1.78 1.61 0.9965 0.6174 0.1407 0.5383 0.235 0.235 0.235 0.19
Netdebt/Ebitda
0.4298 0.5448 0.312 0.0683 -0.2557 0.1762 -0.5318 -0.5318 -0.5318 -0.02
Debt/Ratio
0.1307 0.1496 0.1514 0.1074 0.0458 0.0136 0.0807 0.0333 0.0333 0.0333 0.04
Debt/Equity
0.219 0.2518 0.2365 0.1619 0.0667 0.0198 0.1164 0.2506 0.2506 0.2506 0.17
Debt/Net Income
1.15 4.6 3.67 1.95 1.07 0.2903 0.7692 0.2972 0.2972 0.2972 0.24
Бета
0 1.06 -0.1481 -0.2022 -0.2022 1.82
Индекс Альтмана
0 8.17 3.76 3.76 3.76 9.31


Dividendos

IFRS
Relatórios Anual Trimestral
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Média da indústria Média de 5 anos CAGR 5
Див.выплата, млрд
3.1 7.24 2.4 7.98 4.8 13.79 15.59 25.19 28.98 28.98
Дивиденд
1 3.5 2 2.75 4 7.5 10.5 12.5 5 13.5
Див доход, ао, %
0.129 0.6046 0.3665 0.644 0.8385 1.07 0.986 0.8176 0.8235 0.8206 0.36
Дивиденды / прибыль, %
15.93 3.44 38.08 18.02 36.63 53.7 65.97 29.73 30.26 30.26 20.62


Pague pela sua assinatura

Mais funcionalidades e dados para análise de empresas e portfólio estão disponíveis por assinatura

Inscrever-se

Descansar

IFRS
Relatórios Anual
2020 2021 2022 2023 2024 CAGR 5
Всего задолженность
157.06 161.46
ebit_margin
15.07 19.19 21.08 21.06
Персонал, чел
41000 41000